Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03717792 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vascular Liver Disease Evaluation, Follow Up and Non-Invasive Diagnostics Program

Study acronym: VALID
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 5, 2021 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. 3 versions Re-verified since May 15, 2020, no change to tracked fieldsv2-v4
  2. Study First Submitted
Background Vascular liver disorders (VALDI) are rare diseases, for which knowledge on risk factors, appropriate methods of diagnosis, effect of therapy and prognosis still need to be improved. Aim of the study This project aims to study risk factors, methods of detection, therapy and prognosis in order to elaborate and disseminate updated recommendations for the optimal management of patients with VALDI. Design of the study Data on patients will be collected from baseline (the date of diagnosis) up to 3 years. During this period, data on clinical condition, laboratory results, diagnostic tests, interventions and outcome will be collected anonymously using standardised review of medical charts by one special trained investigator. Only patients with VALDI are eligible to participate.
Trial Details
NCT Number NCT03717792
Lead Sponsor University Hospital, Bonn
Conditions
(from sponsor)		 Vascular Disorder of Liver
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov